Enovix (NASDAQ:ENVX) Updates Q3 2026 Earnings Guidance

Enovix (NASDAQ:ENVX) issued an update on its third quarter 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of -0.170–0.130 for the period, compared to the consensus estimate of -0.150. The company issued revenue guidance of $9.0 million-$10.0 million, compared to the consensus revenue estimate of $10.3 million.

Enovix Trading Down 2.1%

Shares of ENVX stock opened at $4.73 on Thursday. Enovix has a 1 year low of $3.67 and a 1 year high of $14.21. The company has a debt-to-equity ratio of 2.14, a current ratio of 10.97 and a quick ratio of 10.65. The stock’s 50 day simple moving average is $5.47 and its two-hundred day simple moving average is $5.90. The company has a market cap of $1.03 billion, a PE ratio of -5.70 and a beta of 2.32.

Enovix (NASDAQ:ENVX) last announced its earnings results on Wednesday, August 12th. The company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.02. The firm had revenue of $9.02 million during the quarter, compared to analysts’ expectations of $8.43 billion. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The company’s quarterly revenue was up 20.8% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.13) EPS. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. Research analysts predict that Enovix will post -0.79 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently issued reports on ENVX. Benchmark lowered their price target on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. TD Cowen cut their price objective on shares of Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, July 24th. Craig Hallum decreased their price objective on shares of Enovix from $10.00 to $8.00 and set a “buy” rating for the company in a research note on Thursday, May 14th. Oppenheimer reduced their price target on Enovix from $24.00 to $21.00 and set an “outperform” rating on the stock in a report on Thursday, May 14th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a research note on Wednesday, July 8th. Six analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $12.50.

Enovix News Roundup

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Enovix reported second-quarter adjusted EPS of a $0.13 loss, beating analysts’ expected $0.15 loss. Revenue reached $9.02 million, up 20.8% year over year and ahead of consensus estimates. Enovix Reports Second Quarter 2026 Results
• Positive Sentiment: Management continued to highlight potential demand for Enovix’s silicon-anode batteries across smartphones, wearables and defense applications. These markets could support longer-term growth if the company successfully scales production and converts customer interest into commercial orders. ENVX stock falls overnight despite Q2 beat
• Neutral Sentiment: For the third quarter, Enovix guided to an adjusted EPS loss of $0.17 to $0.13, broadly near the $0.15 consensus estimate. The company’s revenue outlook of $9 million to $10 million implies continued growth but remains below the approximately $10.3 million analyst expectation. Enovix Q2 2026 Earnings Call Transcript
• Negative Sentiment: Enovix remains deeply unprofitable, with a quarterly net margin of roughly negative 500% and a negative return on equity. The company also expects another quarterly loss, reinforcing concerns about the timing of profitability and the execution risks involved in scaling its battery technology. Enovix Reports Q2 Loss, Tops Revenue Estimates
• Negative Sentiment: The revenue-guidance shortfall appears to have outweighed the earnings beat, contributing to weaker investor sentiment. ENVX is trading below both its 50-day and 200-day moving averages, indicating continued technical pressure.

Hedge Funds Weigh In On Enovix

Several hedge funds have recently made changes to their positions in the company. Invesco Ltd. lifted its position in Enovix by 65.6% during the 4th quarter. Invesco Ltd. now owns 1,487,425 shares of the company’s stock worth $10,873,000 after acquiring an additional 589,271 shares during the period. Mackenzie Financial Corp purchased a new stake in Enovix in the fourth quarter valued at approximately $77,000. NewEdge Advisors LLC increased its holdings in Enovix by 8.2% in the 4th quarter. NewEdge Advisors LLC now owns 39,607 shares of the company’s stock worth $290,000 after buying an additional 3,012 shares during the period. nVerses Capital LLC purchased a new position in Enovix during the 4th quarter worth approximately $91,000. Finally, VARCOV Co. purchased a new position in Enovix during the 4th quarter worth approximately $1,188,000. 50.92% of the stock is owned by institutional investors and hedge funds.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.